MENU

BIOA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BioAge Labs (BIOA) Ownership - Who owns BioAge Labs?

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging... Show more

Industry: #Chemicals Specialty

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Chemicals Specialty

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Category

Pharmaceuticals

Capitalization

954.4M

P/E Ratio

1.37

Total Cash

383.19M

Projected Growth

N/A

Total Debt

4.03M

Revenue

10.32M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

8.62

Total Debt/Equity

53.55

Revenue/Share

0.27 USD as % of share price

View a ticker or compare two or three

VS

VS

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+18%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

BIOA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BIOA

A.I. Advisor

published General Information

General Information

a producer of sustainable chemicals

Industry PharmaceuticalsGeneric

Profile

Details

Industry

Chemicals Specialty

Address

N/A

Phone

N/A

Employees

N/A

Web

N/A